Compare Kothari Ferment. with Similar Stocks
Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 5.49 times
- The company has been able to generate a Return on Equity (avg) of 1.98% signifying low profitability per unit of shareholders funds
Negative results in Sep 25
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
Kothari Ferment. for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Kothari Fermentation & Biochem Ltd is Rated Strong Sell
Kothari Fermentation & Biochem Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 July 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the company’s current position as of 10 February 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Kothari Fermentation & Biochem Ltd Falls to 52-Week Low Amidst Continued Downtrend
Kothari Fermentation & Biochem Ltd has declined to a fresh 52-week low of Rs.39, marking a significant downturn in its share price amid broader market gains. The stock’s recent performance contrasts sharply with the overall positive trend in the FMCG sector and the broader Sensex index.
Read full news article
Kothari Fermentation & Biochem Ltd: Valuation Shifts Signal Changing Price Attractiveness
Kothari Fermentation & Biochem Ltd, a player in the FMCG sector, has experienced a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. This change, coupled with its negative price-to-earnings ratio and subdued return metrics, raises important questions about its price attractiveness relative to peers and historical benchmarks.
Read full news article Announcements 
Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended On December 31 2025.
07-Feb-2026 | Source : BSEKothari Fermentation & Biochem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve Unaudited Financial Results for the Quarter and Nine Months ended on December 31 2025.
Announcement under Regulation 30 (LODR)-Newspaper Publication
07-Feb-2026 | Source : BSEPlease find attached the newspaper publication regarding the reopening of the Special Window for Re-lodgement of Transfer Requests and Dematerialisation of Physical Shares.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
08-Jan-2026 | Source : BSECompliance Certificate under Reg. 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31st 2025.
Corporate Actions 
13 Feb 2026
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Siddhant Kothari (24.85%)
Dheeraj Kumar Lohia (1.36%)
27.52%
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 0.88% vs -26.20% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is -175.00% vs -206.67% in Jun 2025
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 4.91% vs -1.26% in Mar 2024
YoY Growth in year ended Mar 2025 is 116.50% vs -2,684.21% in Mar 2024






